Catalio Capital Management

Imperative Care

Campbell

Imperative Care is singularly dedicated to finding meaningful answers to unsolved problems in stroke.

Alentis Therapeutics

Allschwil

ALENTIS Therapeutics is a Swiss-French biotech company developing novel therapeutics in advanced liver disease and cancer.

Iambic Therapeutics

San Diego

Iambic is disrupting the therapeutics landscape with its unique AI-driven drug-discovery platform.

Superluminal Medicines

Boston

Superluminal Medicines is a generative biological and chemical company that innovates drug discovery and development processes.

ProSomnus

Pleasanton

ProSomnus designs and manufactures intraoral devices designed to help dentists get patients into therapy with comfort.

Medra

San Francisco

Medra uses AI, robotics, and biology to accelerate life science research and eradicate disease, building a Scientific Physical AI platform to scale lab work and generate orders of magnitude more data for faster drug development and biology

9amHealth

San Diego

Complete care for cardiometabolic health—delivered with compassion and expertise.

Somethings

New York

Somethings aims to end the youth mental health crisis by restoring the teen suicide rate to 6.8 per 100,000 for 42 million U.S. teens, and is building a scaled network of Certified Peer Specialists with Medicaid MCOs and state agencies.

GlycoEra

Zurich

Advancing Glycan Mediated Therapy

Sanguine Biosciences

Woburn

Bridging the gap between patients and researchers

Octant

Emeryville

Octant Bio is a developer of synthetic technology used to improve health and treat disease.

Hippocratic AI

California

Hippocratic AI develops a safety-focused healthcare LLM to improve accessibility and outcomes by applying deep medical expertise; led by CEO Munjal Shah, it has $278 million in funding from investors and six health systems.

Affini-T Therapeutics

Watertown

Affini-T Therapeutics is a biotechnology company developing T-cell therapies for patients suffering from cancer.